The generic drug maker Mylan desires to put to rest the potential merger with Teva Pharmaceuticals which was highly speculated. Teva Pharmaceuticals is an acknowledged international pharmaceutical company which develops, manufactures, and market different generic and branded human medicines, active pharmaceutical ingredients, and medical disposables among others.
Mylan stated that the deal, despite being promising, lacks satisfactory industrial logic. The company emphasized that an adversity is likely to be met in the attempt to win the anti-trust clearances should the deal be pursued.
21:52 Netflix nears 94 million subscribers 10 years after streaming launch16
18:21 Mark Zuckerberg takes the stand in $2 billion lawsuit claiming Oculus theft8
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant18
19:08 U.S. indicts three Takata executives, fines company $1 billion in faulty air bag scandal16